Table 3.

Infusion-Associated Adverse Events

Reported Symptom	Drug	Outcome	Serious Adverse Event?
Chest pain	Bamlanivimab	Known coronary disease, resolved with anti-angina treatment in the emergency department	Yes
Oral tingling	Bamlanivimab	Self-limited	No
Pruritis without rash	Bamlanivimab	Infusion paused and safely resumed, treated with diphenhydramine	No
Hives	Casirivimab/imdevimab	Completed infusion, treated with diphenhydramine and short course of oral methylprednisolone	No
Rigors	Bamlanivimab	Infusion paused, resumed a slower rate, no hypotension	No
Nausea and emesis	Bamlanivimab	Completed infusion, palliated with ondansetron, persistent nausea lasted 4 d	No
Syncope	Bamlanivimab	Infusion terminated, patient was triaged to the emergency department and diagnosed with likely vasovagal etiology, no anaphylactoid features	Yes